Back to Search
PEDRO SEPULVEDA, M.D.
M.D.
Specialist
NPI: 1407931108IndividualAccepts Medicare
Specialties, Licenses & Credentials
Education
OTHER
Class of 1986
Research & Publications (11)
Identification of HLA-A*0201-restricted cytotoxic T-cell epitopes of Trypanosoma cruzi TcP2beta protein in HLA-transgenic mice and patients.
PMID 12737989·Microbes Infect·2003
7-preclinical
In vitro dissolution of melt-derived 45S5 and sol-gel derived 58S bioactive glasses.
PMID 12007211·J Biomed Mater Res·2002
8-other
Characterization of melt-derived 45S5 and sol-gel-derived 58S bioactive glasses.
PMID 11745528·J Biomed Mater Res·2001
4-observational
Dose-dependent behavior of bioactive glass dissolution.
PMID 11745526·J Biomed Mater Res·2001
4-observational
A monoclonal antibody against the immunodominant epitope of the ribosomal P2beta protein of Trypanosoma cruzi interacts with the human beta 1-adrenergic receptor.
PMID 11449375·Eur J Immunol·2001
7-preclinical
Potential use of gelcasting hydroxyapatite porous ceramic as an implantable drug delivery system.
PMID 11165099·Int J Pharm·2001
8-other
Modulation of cardiocyte functional activity by antibodies against trypanosoma cruzi ribosomal P2 protein C terminus.
PMID 10948133·Infect Immun·2000
7-preclinical
DNA-Based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection.
PMID 10948115·Infect Immun·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 910 SAN PEDRO AVE
SAN ANTONIO, TX 78212 - Phone
- (210) 222-9575
Quick Facts
- NPI
- 1407931108
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 40
- Publications
- 11
Are you this provider?
Claim Your Profile